These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 22956959)

  • 1. Redox Regulation of Protein Function via Cysteine S-Nitrosylation and Its Relevance to Neurodegenerative Diseases.
    Akhtar MW; Sunico CR; Nakamura T; Lipton SA
    Int J Cell Biol; 2012; 2012():463756. PubMed ID: 22956959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.
    Nakamura T; Prikhodko OA; Pirie E; Nagar S; Akhtar MW; Oh CK; McKercher SR; Ambasudhan R; Okamoto S; Lipton SA
    Neurobiol Dis; 2015 Dec; 84():99-108. PubMed ID: 25796565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free radicals and antioxidants in normal physiological functions and human disease.
    Valko M; Leibfritz D; Moncol J; Cronin MT; Mazur M; Telser J
    Int J Biochem Cell Biol; 2007; 39(1):44-84. PubMed ID: 16978905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrosative stress in the ER: a new role for S-nitrosylation in neurodegenerative diseases.
    Benhar M; Forrester MT; Stamler JS
    ACS Chem Biol; 2006 Jul; 1(6):355-8. PubMed ID: 17163772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
    Gu Z; Nakamura T; Lipton SA
    Mol Neurobiol; 2010 Jun; 41(2-3):55-72. PubMed ID: 20333559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional Mitochondrial Dynamics in the Pathophysiology of Neurodegenerative Diseases.
    Haun F; Nakamura T; Lipton SA
    J Cell Death; 2013; 6():27-35. PubMed ID: 24587691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-Nitrosylation at the active site decreases the ubiquitin-conjugating activity of ubiquitin-conjugating enzyme E2 D1 (UBE2D1), an ERAD-associated protein.
    Fujikawa K; Nakahara K; Takasugi N; Nishiya T; Ito A; Uchida K; Uehara T
    Biochem Biophys Res Commun; 2020 Apr; 524(4):910-915. PubMed ID: 32051088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases.
    Nakamura T; Lipton SA
    Cell Death Differ; 2011 Sep; 18(9):1478-86. PubMed ID: 21597461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant protein s-nitrosylation in neurodegenerative diseases.
    Nakamura T; Tu S; Akhtar MW; Sunico CR; Okamoto S; Lipton SA
    Neuron; 2013 May; 78(4):596-614. PubMed ID: 23719160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
    Nakamura T; Lipton SA
    Antioxid Redox Signal; 2011 Apr; 14(8):1479-92. PubMed ID: 20812868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrosative Stress in the Nervous System: Guidelines for Designing Experimental Strategies to Study Protein S-Nitrosylation.
    Nakamura T; Lipton SA
    Neurochem Res; 2016 Mar; 41(3):510-4. PubMed ID: 26118537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative Disorders.
    Nakamura T; Oh CK; Zhang X; Tannenbaum SR; Lipton SA
    Antioxid Redox Signal; 2021 Sep; 35(7):531-550. PubMed ID: 33957758
    [No Abstract]   [Full Text] [Related]  

  • 16. ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications.
    Moldogazieva NT; Mokhosoev IM; Feldman NB; Lutsenko SV
    Free Radic Res; 2018 May; 52(5):507-543. PubMed ID: 29589770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview.
    Metodiewa D; Kośka C
    Neurotox Res; 2000 Feb; 1(3):197-233. PubMed ID: 12835102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-based protein modification: formation and site-specificity of protein S-nitrosylation: Could protein S-nitrosylation be the unifying oxidative modification to explain the cellular signaling activity of superoxide and hydrogen peroxide?
    Clement MV
    Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S14. PubMed ID: 26461291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration.
    Nakamura T; Oh CK; Zhang X; Lipton SA
    Free Radic Biol Med; 2021 Aug; 172():562-577. PubMed ID: 34224817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide, S-nitrosylation and neurodegeneration.
    Chung KK; Dawson TM; Dawson VL
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):247-54. PubMed ID: 16191392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.